Skip to Content

MFS Emerging Markets Debt R3 MEDFX

Medalist Rating as of | See MFS Investment Hub
  • NAV / 1-Day Return 11.93  /  −0.15 %
  • Total Assets 7.1 Bil
  • Adj. Expense Ratio
    1.060%
  • Expense Ratio 1.060%
  • Distribution Fee Level Low
  • Share Class Type Retirement, Medium
  • Category Emerging Markets Bond
  • Credit Quality / Interest Rate Sensitivity Low/Extensive
  • Min. Initial Investment
  • Status Open
  • TTM Yield 6.17%
  • Effective Duration 6.44 years

USD | NAV as of Jun 20, 2024 | 1-Day Return as of Jun 20, 2024, 10:18 PM GMT+0

Morningstar’s Analysis MEDFX

Will MEDFX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin MFS Emerging Markets Debt R3's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MEDFX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 12.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Currency Cash CASH_USD

8.93 623.2 Mil
Cash and Equivalents

EUR/USD FWD 20240719 Purchased

5.05 352.4 Mil
Derivative

5 Year Treasury Note Future June 24

2.92 204.0 Mil
Government

10 Year Treasury Note Future June 24

1.94 135.2 Mil
Government

UST Bond 30Yr Future JUN 18 24

1.80 125.3 Mil
Government

Oman (Sultanate Of) 6.75%

1.36 94.7 Mil
Government

Oman (Sultanate Of) 7%

1.18 82.3 Mil
Government

Argentina (Republic of) 3.5%

1.01 70.8 Mil
Government

Angola (Republic of) 9.13%

0.99 69.2 Mil
Government

USD/BRL NDF 20240702 Purchased

0.97 67.6 Mil
Derivative